Ingredients

Moisture-Activated Dry Granulation Part II: The Effects of Formulation Ingredients and Manufacturing-Process Variables on Granulation Quality Attributes

December 02, 2009

In this article, the authors evaluated the effects of the granulating binder level, binder type, water amount, and water-droplet size on the MADG process.

One Voice; Many Possibilities

December 02, 2009

Particularly in a more connected world, individual contributions can make a difference.

Can We Save the Technical Conference?

December 02, 2009

Dumbed-down presentations and poor speaker selections are destroying a valuable industry tool.

An FDA Seal of Approval for Online Information?

December 02, 2009

With so many healthcare and pharmacy websites, consumers could use the agency's nod of support.

Solid-State Chemistry: A Technical Forum

December 02, 2009

Leading experts share insight on polymorphism and crystallization.

Polymorph Screening Strategies: A Q&A with Jan-Olav Henck

December 02, 2009

Polymorph screening is a critical step in developing an active pharmaceutical ingredient for a pharmaceutical formulation.

Using Polyethyline Oxide Blends to Assess the Effect of Excipient Variability

December 02, 2009

The authors discuss a study that demonstrates the use of polyethylene oxide mixtures to investigate the effect of polymer viscosity on formulation robustness.

SOCMA Updates Advocacy Against IST Provisions

November 25, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Society for Chemical Manufacturers and Affiliates (SOCMA) provided an update as to its grassroots efforts regarding the recently passed Chemical and Water Security Act of 2009 (HR 2868).

Week of Nov. 23, 2009: Pfizer Collaborates to Fight Neglected Diseases; Patheon Names VP of Puerto Rico Operations; More...

November 25, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Merck KGaA to build R&D hub in Beijing; Depomed appoints VP of operations; more...

Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire; More...

November 19, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete response letter; Watson appoints VP of global operations; more...